PT894500E - Vacina para streptococcus equi - Google Patents

Vacina para streptococcus equi

Info

Publication number
PT894500E
PT894500E PT98202512T PT98202512T PT894500E PT 894500 E PT894500 E PT 894500E PT 98202512 T PT98202512 T PT 98202512T PT 98202512 T PT98202512 T PT 98202512T PT 894500 E PT894500 E PT 894500E
Authority
PT
Portugal
Prior art keywords
streptococcus equi
equi vaccine
vaccine
vaccines
manufacture
Prior art date
Application number
PT98202512T
Other languages
English (en)
Inventor
Antonius Arnoldus Chris Jacobs
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32669079&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT894500(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PT894500E publication Critical patent/PT894500E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/829—Bacterial vaccine for equine species, e.g. horses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT98202512T 1997-07-29 1998-07-27 Vacina para streptococcus equi PT894500E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97202365 1997-07-29

Publications (1)

Publication Number Publication Date
PT894500E true PT894500E (pt) 2004-10-29

Family

ID=32669079

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98202512T PT894500E (pt) 1997-07-29 1998-07-27 Vacina para streptococcus equi

Country Status (10)

Country Link
US (1) US6120775A (pt)
EP (1) EP0894500B1 (pt)
JP (1) JP4563520B2 (pt)
AT (1) ATE270112T1 (pt)
CA (1) CA2243730C (pt)
DE (1) DE69824794T2 (pt)
DK (1) DK0894500T3 (pt)
ES (1) ES2224331T3 (pt)
HU (1) HU223762B1 (pt)
PT (1) PT894500E (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6682745B1 (en) 1998-07-28 2004-01-27 Christiaan Antonius Arnoldus Jacobs Use of bacterium for manufacture of a vaccine
JP4339978B2 (ja) * 1999-01-26 2009-10-07 インターベツト・インターナシヨナル・ベー・ベー ワクチンの製造のための細菌の使用
GB2370770B (en) * 2001-01-03 2005-06-01 Simon Connolly Uses of Streptococcus Vaccines
US20030129161A1 (en) * 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
GB0404586D0 (en) * 2004-03-01 2004-04-07 Britannia Pharmaceuticals Ltd Improvements in or relating to organic materials
WO2007126885A2 (en) * 2006-03-28 2007-11-08 The Trustees Of The University Of Pennsylvania Live, attenuated pneumococcal vaccine
CA2647566C (en) * 2006-03-29 2017-01-03 Merial Limited Vaccine against streptococci
CA2708260A1 (en) 2007-12-13 2009-06-18 Intervacc Ab Improved immunizing composition
EA029938B1 (ru) * 2015-04-09 2018-05-31 Тоо "Акынтай" Вакцина против мыта лошадей

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110433A (en) * 1976-04-23 1978-08-29 Philips Roxane, Inc. Equine rhinopneumonitis virus
JPS58500948A (ja) * 1981-06-19 1983-06-09 イギリス国 「う」蝕症からの保護
AR241545A1 (es) * 1985-07-12 1992-08-31 Cornell Res Foundation Inc Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos.
US4788059A (en) * 1985-07-15 1988-11-29 Coopers Animal Health, Inc. Equine strangles vaccine and the method of preparing and using the same
IL86583A0 (en) * 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
DE3853683T2 (de) * 1987-10-07 1995-08-31 Univ Washington Verfahren zur erhaltung eines erwünschten rekombinanten gens in einer genetischen zellpopulation.
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.

Also Published As

Publication number Publication date
HUP9801705A3 (en) 2001-11-28
DE69824794D1 (de) 2004-08-05
EP0894500B1 (en) 2004-06-30
DK0894500T3 (da) 2004-11-15
ES2224331T3 (es) 2005-03-01
HU9801705D0 (en) 1998-09-28
CA2243730C (en) 2009-12-22
JP4563520B2 (ja) 2010-10-13
US6120775A (en) 2000-09-19
HU223762B1 (hu) 2005-01-28
JPH11100329A (ja) 1999-04-13
DE69824794T2 (de) 2004-11-25
EP0894500A1 (en) 1999-02-03
CA2243730A1 (en) 1999-01-29
ATE270112T1 (de) 2004-07-15
HUP9801705A2 (hu) 1999-05-28

Similar Documents

Publication Publication Date Title
PT865297E (pt) Composicoes de vacinas para administracao intranasal compreendendo quitosano e suas utilizacoes
CY1106234T1 (el) Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus
CY2009014I1 (el) Εμβολιο εναντι αντιγονων απο βακτηριδια
CY1110914T1 (el) Δικυκλο-πυραζολες δραστικες ως αναστολεις kinασων, διεργασια για την παρασκευη τους και φαρμακευτικες συνθεσεις που τις περιλαμβανουν
BRPI9700768B8 (pt) vacina viva para combater infecção por streptococcus em cavalos.
DE69117532D1 (de) Orale präparate
ATE556596T1 (de) Regulierte attenuierung von lebendimpfstoffen zur verbesserung der kreuzimmunitätsschutzfunktion
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
CY1112411T1 (el) Αποστειρωση με οζον, υγρασια και ακορεστη ενωση
HUP0203056A1 (hu) Vakcinakészítmény
BRPI9912663B8 (pt) vacina contra cáncer e polipeptìdeo.
BR9909668A (pt) Uso de compostos de organofósforo para o tratamento terapêutico e profilático de infecções
HUP0302636A2 (hu) Hasított burkolt víruskészítmény
HUP0301634A2 (hu) Hőmérséklet-érzékeny, élő vakcina Mycoplasma hyopneumoniaera
ATE511855T1 (de) Adjuvansformulierung zur scheimhaut-applikation
CY1104996T1 (el) 9α-αζαλιδια εχοντα αντιβακτηριακην δρασιν
DE69738271D1 (de) Rotavirus-impfstoff
PT894500E (pt) Vacina para streptococcus equi
CY1108178T1 (el) Βακτηριο που προκαλει νοσο των πουλερικων και εμβολιο προερχομενο εξ' αυτου
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
DK1109574T3 (da) Vaccine mod seksuelt overförte sygdomme
ATE269104T1 (de) Salmonella impfstoff, der keinen antikörper gegen flagellin oder gegen flagella induziert
ATE249740T1 (de) Orale antimikrobielle und desodoriende zusammensetzungen
ES2136064T3 (es) Vacunas de toxoide de pasteurella multocida.
ES2169022T3 (es) Utilizacion de derivados de (piridil-metil-sulfinil)-1-h-bencimidazol para el tratamiento de enfermedades provocadas por helicobacter.